Mental health can become a concern for patients with chronic conditions such as peripheral neuropathy. During recent months when the pandemic has disrupted many of our usual routines, mental health for patients and their families can become even more of an issue.
The Foundation for Peripheral Neuropathy asked two experts on the subject for their views on the current state of mental health for patients with peripheral neuropathy. Dr. Shannon O’Neill and Dr. Pojen Deng from Mt. Sinai Hospitals in New York shared their observations and recommendations with us.
Changes in B12, MMA and Homocysteine Linked to Peripheral Neuropathy
According to results of a systematic review and meta-analysis, patients with PN were more likely to have elevated methylmalonic acid (MMA) concentrations and homocysteine levels and depleted vitamin B12 regardless of the disease believed to have caused the PN.